The IMiD target CRBN determines HSP90 activity toward transmembrane proteins essential in multiple myeloma
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The IMiD target CRBN determines HSP90 activity toward transmembrane proteins essential in multiple myeloma
Authors
Keywords
-
Journal
MOLECULAR CELL
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-02-11
DOI
10.1016/j.molcel.2020.12.046
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of lenalidomide resistance pathways in myeloma and targeted resensitization using cereblon replacement, inhibition of STAT3 or targeting of IRF4
- (2019) Yuan Xiao Zhu et al. Blood Cancer Journal
- Structure of the human LAT1–4F2hc heteromeric amino acid transporter complex
- (2019) Renhong Yan et al. NATURE
- Membrane protein-regulated networks across human cancers
- (2019) Chun-Yu Lin et al. Nature Communications
- Anticalin® Proteins as Therapeutic Agents in Human Diseases
- (2018) Christine Rothe et al. BIODRUGS
- Transmembrane Domain Recognition during Membrane Protein Biogenesis and Quality Control
- (2018) Alina Guna et al. CURRENT BIOLOGY
- Peptide Level Turnover Measurements Enable the Study of Proteoform Dynamics
- (2018) Jana Zecha et al. MOLECULAR & CELLULAR PROTEOMICS
- A chemical compound inhibiting the Aha1–Hsp90 chaperone complex
- (2017) Sandrine C. Stiegler et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The HSP90 chaperone machinery
- (2017) Florian H. Schopf et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma
- (2017) Michel Attal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target
- (2016) M. Bolzoni et al. BLOOD
- Immunomodulatory drugs disrupt the cereblon–CD147–MCT1 axis to exert antitumor activity and teratogenicity
- (2016) Ruth Eichner et al. NATURE MEDICINE
- Atomic structure of Hsp90-Cdc37-Cdk4 reveals that Hsp90 traps and stabilizes an unfolded kinase
- (2016) K. A. Verba et al. SCIENCE
- The Mechanism of Hsp90 ATPase Stimulation by Aha1
- (2016) Annemarie Wolmarans et al. Scientific Reports
- New Perspectives Offered by Nuclear Medicine for the Imaging and Therapy of Multiple Myeloma
- (2016) Charles Mesguich et al. Theranostics
- Identification of proteins associated with Aha1 in HeLa cells by quantitative proteomics
- (2015) Liang Sun et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Mechanisms of Integral Membrane Protein Insertion and Folding
- (2015) Florian Cymer et al. JOURNAL OF MOLECULAR BIOLOGY
- Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS
- (2015) Jan Krönke et al. NATURE
- Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma
- (2015) A. Keith Stewart et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phthalimide conjugation as a strategy for in vivo target protein degradation
- (2015) G. E. Winter et al. SCIENCE
- c-Abl Mediated Tyrosine Phosphorylation of Aha1 Activates Its Co-chaperone Function in Cancer Cells
- (2015) Diana M. Dunn et al. Cell Reports
- System l amino acid transporter LAT1 accumulates O-(2-fluoroethyl)-l-tyrosine (FET)
- (2014) A. Habermeier et al. AMINO ACIDS
- Identification of cereblon-binding proteins and relationship with response and survival after IMiDs in multiple myeloma
- (2014) Y. X. Zhu et al. BLOOD
- Expression of L-type amino acid transporter 1 (LAT1) as a prognostic and therapeutic indicator in multiple myeloma
- (2014) Atsushi Isoda et al. CANCER SCIENCE
- Structure of the DDB1–CRBN E3 ubiquitin ligase in complex with thalidomide
- (2014) Eric S. Fischer et al. NATURE
- Disruption of the PRKCD–FBXO25–HAX-1 axis attenuates the apoptotic response and drives lymphomagenesis
- (2014) Ursula Baumann et al. NATURE MEDICINE
- Immunomodulatory agents lenalidomide and pomalidomide co-stimulate T cells by inducing degradation of T cell repressors Ikaros and Aiolos via modulation of the E3 ubiquitin ligase complex CRL4CRBN
- (2013) Anita K. Gandhi et al. BRITISH JOURNAL OF HAEMATOLOGY
- PASylation: a biological alternative to PEGylation for extending the plasma half-life of pharmaceutically active proteins
- (2013) M. Schlapschy et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Lenalidomide Causes Selective Degradation of IKZF1 and IKZF3 in Multiple Myeloma Cells
- (2013) J. Kronke et al. SCIENCE
- The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
- (2013) G. Lu et al. SCIENCE
- 1D and 2D annotation enrichment: a statistical method integrating quantitative proteomics with complementary high-throughput data
- (2012) Juergen Cox et al. BMC BIOINFORMATICS
- Quantitative Analysis of Hsp90-Client Interactions Reveals Principles of Substrate Recognition
- (2012) Mikko Taipale et al. CELL
- Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide
- (2012) A Lopez-Girona et al. LEUKEMIA
- SCFFbxo9 and CK2 direct the cellular response to growth factor withdrawal via Tel2/Tti1 degradation and promote survival in multiple myeloma
- (2012) Vanesa Fernández-Sáiz et al. NATURE CELL BIOLOGY
- Cereblon expression is required for the antimyeloma activity of lenalidomide and pomalidomide
- (2011) Y. X. Zhu et al. BLOOD
- Biological and Structural Basis for Aha1 Regulation of Hsp90 ATPase Activity in Maintaining Proteostasis in the Human Disease Cystic Fibrosis
- (2010) Atanas V. Koulov et al. MOLECULAR BIOLOGY OF THE CELL
- Asymmetric Activation of the Hsp90 Dimer by Its Cochaperone Aha1
- (2010) Marco Retzlaff et al. MOLECULAR CELL
- Identification of a Primary Target of Thalidomide Teratogenicity
- (2010) T. Ito et al. SCIENCE
- Bidirectional Transport of Amino Acids Regulates mTOR and Autophagy
- (2009) Paul Nicklin et al. CELL
- Cereblon is expressed in the retina and binds to voltage-gated chloride channels
- (2009) Bettina Hohberger et al. FEBS LETTERS
- The Cdc14B-Cdh1-Plk1 Axis Controls the G2 DNA-Damage-Response Checkpoint
- (2008) Florian Bassermann et al. CELL
- A novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex against pancreatic cancer cells
- (2008) T. Zhang et al. MOLECULAR CANCER THERAPEUTICS
- Dysregulation of large-conductance Ca2+-activated K+ channel expression in nonsyndromal mental retardation due to a cereblon p.R419X mutation
- (2008) Joseph J. Higgins et al. NEUROGENETICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More